Evidence map›Paper›PMID 39992104›Full record

ArticleAntimicrobial agents and chemotherapy2025

Deletion of the

Makoto Hirai, Meiji Arai, Soki Hayamichi, Ayako Uchida, Megumi Sudo, Rie Kubota, Naoaki Shinzawa, Toshihiro Mita

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Makoto Hirai *Department of Tropical Medicine and Parasitology, Faculty of Medicine, Juntendo University, Bunkyo-ku Hongo, Tokyo, Japan.ORCID 0000-0002-5001-9653
Meiji Arai *Department of International Medical Zoology, School of Medicine, Kagawa University, Kida, Kagawa, Japan.
Soki HayamichiDepartment of Tropical Medicine and Parasitology, Faculty of Medicine, Juntendo University, Bunkyo-ku Hongo, Tokyo, Japan.
Ayako UchidaDepartment of Tropical Medicine and Parasitology, Faculty of Medicine, Juntendo University, Bunkyo-ku Hongo, Tokyo, Japan.
Megumi SudoDepartment of Tropical Medicine and Parasitology, Faculty of Medicine, Juntendo University, Bunkyo-ku Hongo, Tokyo, Japan.
Rie KubotaDepartment of Parasitology and Tropical Medicine, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Bunkyo-ku Yushima, Tokyo, Japan.
Naoaki ShinzawaDepartment of Parasitology and Tropical Medicine, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Bunkyo-ku Yushima, Tokyo, Japan.
Toshihiro MitaDepartment of Tropical Medicine and Parasitology, Faculty of Medicine, Juntendo University, Bunkyo-ku Hongo, Tokyo, Japan.

Funding

Japan Agency for Medical Research and Development (AMED) JP23fk0108680Japan Agency for Medical Research and Development (AMED) JP23wm0225036MEXT | Japan Society for the Promotion of Science (JSPS) 18K07095
6 · The paper itself

Abstract

Malaria parasites acquire drug resistance through genetic changes, the mechanisms of which remain incompletely understood. Understanding the mechanisms of drug resistance is crucial for the development of effective treatments against malaria, and for this purpose, new genetic tools are needed. In a previous study, as a forward genetic tool, we developed the rodent malaria parasite

Indexed as

AntimalarialsChloroquineDrug ResistanceMembrane Transport ProteinsPlasmodium bergheiProtozoan ProteinsQuinolinesAnimalsFemaleMalariaMicePiperazinesAntimalarialsChloroquineMembrane Transport ProteinspiperaquinePiperazinesProtozoan ProteinsQuinolinesmutatorpiperaquine resistancerodent malaria parasite

Identifiers

PMID39992104
PMCPMC11963562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.